RiverStone International Holdings (Riverstone International) is pleased to announce the appointment of Charlotte Pritchard as UK CEO effective 5 January, subject to regulatory approval. Pritchard succeeds Andrew Creed who, as previously announced, will become group president (also effective 5 January) while continuing his role as group CFO.
Pritchard brings more than 16 years of experience in financial services to the role and has spent the past eight years with RiverStone International, most recently as group risk and compliance director, where she has been responsible for the oversight of all risk and compliance matters, and has successfully provided strategic leadership to cross-border teams across five territories.
Since 2010 RiverStone International has completed 47 transactions acquiring US$17.7 billion in gross liabilities. In 2024 the group reported $300 million in adjusted profit before tax with a 19.1% return on opening adjusted tangible book value.
Luke Tanzer, group chief executive officer of RiverStone International, said: “We are delighted to appoint Charlotte as UK CEO. Over the past eight years, she has developed strong relationships and delivered consistent results for RiverStone International. She brings a wealth of experience to the role and has consistently demonstrated her capabilities in her time as group risk and compliance director. We look forward to seeing her seize this opportunity.”
Andrew Creed, group president of RiverStone International, added: “I am pleased that Charlotte will be succeeding me as UK CEO. Her strong presence and proven track record at RiverStone International make her an outstanding choice for the role. I have complete confidence in her ability to excel and drive the continued success of our UK business.”
Charlotte Pritchard said “I’m genuinely excited to step into the role of UK CEO and build on the fantastic work that Andy has done over the last two years. I look forward to working closely with the executive team and the UK Boards as we shape the next chapter together”